This topic contains a solution. Click here to go to the answer

Author Question: Caregivers of one-year-olds must be very aware of safety factors because these children are both ... (Read 46 times)

Chelseaamend

  • Hero Member
  • *****
  • Posts: 545
Caregivers of one-year-olds must be very aware of safety factors because these children are both very curious and unaware of safety precautions.
 
  Indicate whether this statement is true or false.

Question 2

Arnold Gessells research in the early parts of the twentieth century laid the groundwork for much of what we know today about childrens development.
 
  Indicate whether this statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittanywood

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

ANS: T

Answer to Question 2

ANS: T




Chelseaamend

  • Member
  • Posts: 545
Reply 2 on: Sep 11, 2018
Great answer, keep it coming :)


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library